posted
Its backkkkkkk! biopharmaceutical companies working on vaccines and treatments for avian flu, continuing gains from the regular session stemming from reports that an Indonesian man who died from the H5N1 virus Monday may have caught it from his son. The World Health Organization is still investigating the case. Generex Biotechnology Corp.'s stock added 19 cents, or 10.3 percent, to $2.03 in after-hours trading. The Canadian company's stock had closed up 17 cents, or 10.2 percent, at $1.84 on the Nasdaq.
should be interesting in the days to come
Posts: 55 | From: jersey | Registered: May 2006
| IP: Logged |
posted
nah i'm new at posting but i read the boards for like 2 weeks beofre i wrote anything , NDOL GOT ME HERE I SOLD AT 1.30 BUT READING THE BOARDS CONVINCE ME TO BUY 1000 SHARES AT 1.20 AND LOST MAD MONEY
Posts: 55 | From: jersey | Registered: May 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
